This edition of our newsletter begins with a new article about the evidence-based strategies that are currently available for modulating the gut microbiota.
Next up, new longitudinal research, which integrates multi-omics, patient and gastrointestinal data, reveals previously unidentified targets that accompany changes in IBS activity. You will also come across a new study that supports the role of probiotic supplementation in shaping the gut microbiota of preterm infants towards that of their full-term counterparts.
Finally, a new proof-of-concept study shows that the gut microbiota of C-section-born infants can be restored after delivery via orally administered maternal fecal microbiota transplantation.
The GMFH publishing team